Medical Services Completes Documentation for CE Approval in Europe
June 13 2006 - 2:59PM
PR Newswire (US)
EDMONTON, Alberta, June 13 /PRNewswire-FirstCall/ -- Medical
Services International Inc. (OTC:MSITF) is pleased to announce that
it has completed the necessary documentation to apply for
certification (CE status) of its VScan HIV test kits in Europe. As
indicated in a March 29, 2006 press release, Medical Services
agreed to a proposal from a European pharmaceutical company whereby
they would pay the costs necessary, look after the submission of
all data and complete any and all other procedures required to
obtain certification of the VScan HIV test kit. The Company has now
received all required documentation from Medical Services and has
indicated that the application will be submitted to the appropriate
authorities as soon as possible. It is our understanding that
preliminary meetings have already taken place. Certification of the
Vscan HIV test kit will allow the VScan HIV test kit to be sold in
an additional 25 countries and should result in additional sales of
up to $4,000,000 US per year. Preliminary marketing in several of
these countries shows that there is significant demand for an HIV
test kit that is accurate and easy to use using whole blood.
Testing throughout the world by health departments continues to
show that the VScan HIV test kit fits this criteria. About VScan
The VScan rapid test kit is a single use, disposable, accurate,
cost effective, easy to use, test for the screening of HIV 1&2,
Hepatitis B&C, Tuberculosis (TB), Dengue Fever, West Nile,
Syphilis, Malaria, and Prostate Cancer. The kits cannot be sold in
Canada. Medical Services International Inc. trades in the United
States on the NDB Pinksheets under the symbol "MSITF". For further
information, please contact Robert Talbot at (780) 430 6363 or
http://www.medicalservicesintl.com/ or
http://www.minerva-biotech.com/ . NOTE: Certain statements in this
press release are "forward-looking statements" within the meaning
of the Private Securities Act of 1995. Such statements involve
known and unknown risks, uncertainties and other factors that may
cause results to differ materially. Such risks, uncertainties and
other factors include but are not limited to new economic
conditions, risk in product development, market acceptance of new
products and continuing product demand, level of competition and
other factors described in Company reports and other filings with
regulatory bodies. DATASOURCE: Medical Services International Inc.
CONTACT: Robert Talbot of Medical Services International Inc.,
+1-780-430-6363 Web site: http://www.medicalservicesintl.com/
http://www.minerva-biotech.com/
Copyright